←RETURN TO 2026 IPO RADAR DECK (135 OFFERINGS)COHORT STANDING: #12 of 135
Verified SEC Filing/Calendar Year 2026
NASDAQHealth Care
$VOGX
MOONSHOT (>+50%)
Vogenx
Legal Entity: Vogenx, Inc.
OFFER PRICE$13.00
CURRENT PRICE
$17.11
CUMULATIVE RETURN
+81.92%
PRICING DATE: 8/12/2026SEC FILING SNAPSHOT
SECTION 01 // FORENSIC TEARDOWN
The Seagull Executive Verdict
SURVIVAL RATING: WINNER
WHAT THE BUSINESS DOES
Developing mizaglifozin for the treatment of gastroparesis. Operates as a clinical-stage testing apparatus with no commercial sales.
THE WALL STREET PITCH
Addressing a massive unmet clinical need in gastroparesis with a novel therapeutic mechanism.
THE COLD REALITY
Low-float manipulation; current valuation is artificially supported by a lack of tradable shares which will collapse upon lock-up expiration.
SECTION 02 // CAPITAL ALLOCATION
Capital Formation & Float Scarcity
FLAG: TREASURY GROWTH
Gross Proceeds
$81.9M
Cash extracted from market
Post-Money Value
$585.0M
Total company valuation
Public Float %
14%
Shares available to public
Secondary Share %
0%
Insider cash extraction
CAPITAL USE ANALYSIS
Proceeds directed to balance sheet and operations.
SECTION 03 // SUPPLY SHOCK AUDITOR
Insider Lock-Up Expiration
VC DUMP RISK: CRITICAL
Expiration Calendar Date
2027-02-08
91 DAYS REMAINING
Supply Shock Multiplier
4.8x
Float expansion ratio upon unlock
Lockup Duration
180 Days
Contractual restriction window
SECTION 05 // COHORT BENCHMARK
Sector Peer & Cohort Telemetry
RANK: #12 of 135
2026 Cohort Standing
#12 of 135
Out of 135 total 2026 IPO offerings
Sector Median Return
+21.64%
Health Care sector midpoint
Sector Win Rate
78%
% of peer IPOs trading in profit
PERFORMANCE VS PEERS
Vogenx is currently trading above the Health Care sector median of 21.64%. Across the entire 2026 calendar year cohort, only 78% of Health Care offerings have sustained a positive return above their initial offer price.